Please note that our offices will be closed from December 22 to January 2 inclusively.
VuePoint IDS wishes you Happy Holidays!
Please note that our offices will be closed from December 22 to January 2 inclusively.
New target for AMD treatment
Researchers have identified a new genetic target for AMD treatment.
One of the genes associated with the risk of AMD is the complement factor H (CFH) gene. It codes the factor H (FH) protein, which protects our eyes from attacks from our own immune system.
The researchers discovered that in the back of the eye, it is not the factor H protein that acts as a protector, but rather the factor “H-like 1” (FHL-1) protein. The protein’s reduced size (about a third of factor H) allows it to get to the structures at the back of the eye, whereas FH cannot.
An insufficient amount of FHL-1 in the back of the eye leaves the eyes vulnerable to inflammation and can lead to vision loss.
For further information: http://www.jimmunol.org/content/early/2014/10/10/jimmunol.1401613.abstract
Dzmitry Samal launches Orphee
Paris-based Belarusian designer Dzmitry Samal has launched its new Orphee design. Inspired by skeleton joints, the frame is made using 3D printing technology. The frames come in acetate and are available in five colours. The temples feature openings to provide better peripheral vision. http://www.dzmitrysamal.com/
theo releases new Mille models
theo has released seven Mille models in gold and silver colours. The silver-coloured styles are coated with palladium, whereas the gold-coloured ones are coated with palladium and gold. The latter ones carry a label of authenticity on the temple to certify that they are made with real 24-karat gold. http://www.theo.be/
